In this respect, monomeric quinoline-based tracers (Jansen et al. 2013) that act as FAP inhibitors (FAPIs) demonstrated promising results in preclinical studies but also in clinical PET imaging in 15 different tumor entities (Kratochwil et al. 2019; Lindner et al. 2018). The gene discussed is FAP; the disease is neoplasm.